PharmaCyte Biotech, Inc. Appoints Leonard Makowka as Senior Strategic Advisor
March 13, 2017 at 09:00 am EDT
Share
PharmaCyte Biotech, Inc. announced that it has named Leonard Makowka, M.D., Ph.D. as Senior Strategic Advisor to the Chief Executive Officer and Board of Directors. Dr. Makowka will serve as a major resource to PharmaCyte in developing therapies that utilize the Cell-in-a-Box technology. He will also assist the company in developing strategic and scientific plans, identifying and introducing potential business collaborators and clinical partners and facilitating joint ventures, licensing arrangements and other strategic transactions with PharmaCyte.
PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. It is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. It is also focused on developing therapies for pancreatic and other solid cancerous tumors by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. It is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant.
PHARMACYTE BIOTECH, INC. 